![Gudrun Anstrén](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gudrun Anstrén
Direttore/Membro del Consiglio presso WNTRESEARCH AB
Provenienza dei contatti di primo grado di Gudrun Anstrén
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Other | 19 | |
Public Company | Pharmaceuticals: Major | 11 | |
Wntresearch Incentive AB
3
| Private Company | 3 | |
Apotekarsocieteten
1
| Non-Profit Organization | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gudrun Anstrén tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer Chief Executive Officer | |
University of Uppsala | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
Oblique Therapeutics AB
![]() Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
University of Gothenburg | College/University | Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
XINTELA AB | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
University of Linköping
![]() University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Handelshögskolan i Göteborg | College/University | Graduate Degree Undergraduate Degree | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact | |
IDOGEN AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin | |
LIDDS AB | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Chalmers University of Technology | College/University | Graduate Degree Graduate Degree | |
PROBI AB | Biotechnology | Director/Board Member Director/Board Member | |
A Bioscience Incentive AB | Chairman | ||
Webster University Geneva | College/University | Undergraduate Degree | |
Heart-Lung Foundation Research Council | Chairman | ||
Abcentra LLC | Director/Board Member | ||
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Chief Executive Officer | |
NANOLOGICA AB | Pharmaceuticals: Major | Director/Board Member | |
FLERIE INVEST AB | Pharmaceuticals: Major | Chief Operating Officer | |
Targinta AB
![]() Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chief Executive Officer | |
Baricol Bariatrics AB
![]() Baricol Bariatrics AB Medical SpecialtiesHealth Technology Baricol Bariatrics AB develops, produces, and sells customized products and services for people who have undergone obesity surgery. The firm offers vitamins and minerals. Its customer include medical experts such as doctors and dieticians and people with long experience in the pharmaceutical industry. The company is headquartered in Gothenburg, Sweden. | Medical Specialties | Director/Board Member | |
EVAXION BIOTECH A/S | Biotechnology | Chief Executive Officer | |
Investmentaktiebolaget Akkumula | Director/Board Member | ||
Albonja AB | Director/Board Member | ||
Mindforce Game Lab AB
![]() Mindforce Game Lab AB Packaged SoftwareTechnology Services Mindforce Game Lab AB creates games for people with medical conditions, called Playtients™, to help them develop healthy habits. The games are designed to act as companions on the journey to better health and are created by bringing together leading life scientists and top game designers. The CEO of the Swedish company is Anders Rabbe. | Packaged Software | Chief Executive Officer | |
Epicyt Pharma AB
![]() Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Pharmaceuticals: Major | Director/Board Member | |
Vetenskapsrådet | Director/Board Member | ||
Atlas Therapeutics AB
![]() Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Chief Executive Officer | |
ACTIVE BIOTECH AB | Biotechnology | Director/Board Member | |
PetaJoule AB | Director/Board Member | ||
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
WC Likvid AB
![]() WC Likvid AB Real Estate DevelopmentFinance WC Likvid AB owns and manages movable and immovable property. The company was founded by Tadeusz Wojciech Wieloch on June 5, 2009 and is headquartered in Staffanstorp, Sweden. | Real Estate Development | Chairman | |
Ball Beverage Packaging Fosie AB
![]() Ball Beverage Packaging Fosie AB Miscellaneous ManufacturingProducer Manufacturing Part of Ball Corp., Ball Beverage Packaging Fosie AB is a Swedish company that manufactures consumer packaging products and solutions. The company is based in Malmö, Sweden. | Miscellaneous Manufacturing | Comptroller/Controller/Auditor | |
PolyPeptide Laboratories (Sweden) AB
![]() PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology PolyPeptide Laboratories (Sweden) AB specializes in the production of proprietary peptides. The firm manufactures polypeptide, custom peptide Synthesis, peptide synthesis, and generic peptide. Its peptides products are part of several different pharmaceutical products. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Biotechnology | Chief Administrative Officer | |
Rechon Life Science AB
![]() Rechon Life Science AB Pharmaceuticals: MajorHealth Technology Rechon Life Science AB manufactures medicines. It specializes in aseptic injectables and sprays for nasal and oral administration. The firm's products include Iron Sucrose Injection. The firm's services include formulation and analytical development, clinical trial, stability studies, and storage and distritutions. The company is headquartered in Limhamn, Sweden. | Pharmaceuticals: Major | Chief Administrative Officer | |
PHARMIVA AB (PUBL) | Miscellaneous Commercial Services | Director of Finance/CFO | |
Skane University Hospital
![]() Skane University Hospital Hospital/Nursing ManagementHealth Services Skane University Hospital operates a search service called Hitta Vård, which provides contact information for public and private healthcare providers in the Skåne region of Sweden. The private company is based in Malmö, Sweden. The service is financed by Region Skåne. | Hospital/Nursing Management | Corporate Officer/Principal | |
Kajt Biotech AB | Chairman | ||
Danske Bank A/S (Sweden) | Investment Banks/Brokers | Analyst-Equity | |
Medscienta AB | Chairman | ||
ABLIVA AB | Pharmaceuticals: Major | Chief Executive Officer |
Statistiche
Distribuzione geografica
Svezia | 48 |
Svizzera | 2 |
Stati Uniti | 2 |
Danimarca | 2 |
Settori
Health Technology | 25 |
Consumer Services | 10 |
Commercial Services | 4 |
Finance | 3 |
Technology Services | 2 |
Posizioni
Director/Board Member | 114 |
Corporate Officer/Principal | 57 |
Chief Executive Officer | 29 |
Chairman | 25 |
Chief Tech/Sci/R&D Officer | 16 |
Contatti più connessi
Insiders | |
---|---|
Claes Tomas Post | 30 |
Kjell Sture Stenberg | 29 |
Per Gunnar Fernström | 21 |
Dennis Bang Henriksen | 19 |
Peter Jan Sture Ström | 15 |
Erik Kinnman | 14 |
Christer Nordstedt | 14 |
Ulf Björklund | 14 |
Jan Nilsson | 12 |
Per-Ola Forsberg | 11 |
Mattias Münnich | 9 |
Anders Rabbe | 9 |
Per Norlén | 9 |
Thomas Pålsson | 9 |
Pernilla Sandwall | 8 |
- Borsa valori
- Insiders
- Gudrun Anstrén
- Connessioni Società